Gilead Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
CEODaniel P. O'Day
CEODaniel P. O'Day
Employees17,600
Employees17,600
HeadquartersFoster City, California
HeadquartersFoster City, California
Founded1987
Founded1987
Employees17,600
Employees17,600
GILD Key Statistics
Market cap150.83B
Market cap150.83B
Price-Earnings ratio19.01
Price-Earnings ratio19.01
Dividend yield2.57%
Dividend yield2.57%
Average volume6.38M
Average volume6.38M
High today$122.74
High today$122.74
Low today$121.19
Low today$121.19
Open price$122.46
Open price$122.46
Volume4.54M
Volume4.54M
52 Week high$128.70
52 Week high$128.70
52 Week low$88.57
52 Week low$88.57
Stock Snapshot
Gilead Sciences(GILD) stock is priced at $122.00, giving the company a market capitalization of 150.83B. It carries a P/E multiple of 19.01 and pays a dividend yield of 2.6%.
On 2026-01-02, Gilead Sciences(GILD) stock moved within a range of $121.19 to $122.74. With shares now at $122.00, the stock is trading +0.7% above its intraday low and -0.6% below the session's peak.
Trading activity shows a volume of 4.54M, compared to an average daily volume of 6.38M.
The stock's 52-week range extends from a low of $88.57 to a high of $128.70.
The stock's 52-week range extends from a low of $88.57 to a high of $128.70.
Analyst ratings
72%
of 29 ratingsBuy
72.4%
Hold
27.6%
Sell
0%
People also own
Based on the portfolios of people who own GILD. This list is generated using Robinhood data, and it’s not a recommendation.